Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126641951 | 12664195 | 1 | I | 20100618 | 20100707 | 20160818 | 20160818 | EXP | US-ASTELLAS-2010002766 | ASTELLAS | 66.97 | YR | M | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126641951 | 12664195 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | U | 21743 | 100 | MG | TABLET | QD | ||||||
| 126641951 | 12664195 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | 21743 | 75 | MG | TABLET | QD | |||||||
| 126641951 | 12664195 | 3 | SS | VISMODEGIB | VISMODEGIB | 1 | Oral | U | 0 | 150 | MG | CAPSULE | QD | ||||||
| 126641951 | 12664195 | 4 | SS | VISMODEGIB | VISMODEGIB | 1 | 0 | CAPSULE | |||||||||||
| 126641951 | 12664195 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2, DAYS 1, 8, 15 (3 IN I CYCLE) | U | 0 | 1000 | MG/M**2 | FORMULATION UNKNOWN | ||||||
| 126641951 | 12664195 | 6 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126641951 | 12664195 | 7 | C | LOVASTATIN. | LOVASTATIN | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126641951 | 12664195 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126641951 | 12664195 | 9 | C | PROPAFENONE. | PROPAFENONE | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126641951 | 12664195 | 1 | Pancreatic carcinoma |
| 126641951 | 12664195 | 2 | Adenocarcinoma pancreas |
| 126641951 | 12664195 | 3 | Pancreatic carcinoma |
| 126641951 | 12664195 | 4 | Adenocarcinoma pancreas |
| 126641951 | 12664195 | 5 | Pancreatic carcinoma |
| 126641951 | 12664195 | 6 | Product used for unknown indication |
| 126641951 | 12664195 | 7 | Product used for unknown indication |
| 126641951 | 12664195 | 8 | Product used for unknown indication |
| 126641951 | 12664195 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126641951 | 12664195 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126641951 | 12664195 | Decreased appetite | |
| 126641951 | 12664195 | Dehydration | |
| 126641951 | 12664195 | Diarrhoea | |
| 126641951 | 12664195 | Fatigue | |
| 126641951 | 12664195 | Hypokalaemia | |
| 126641951 | 12664195 | Hyponatraemia | |
| 126641951 | 12664195 | Lung infection | |
| 126641951 | 12664195 | Nausea | |
| 126641951 | 12664195 | Non-cardiac chest pain | |
| 126641951 | 12664195 | Pneumonia | |
| 126641951 | 12664195 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126641951 | 12664195 | 1 | 20100511 | 0 | ||
| 126641951 | 12664195 | 3 | 20100511 | 0 | ||
| 126641951 | 12664195 | 5 | 20100511 | 0 |